Align Technology, Inc. (ALGN) currently reads Oversold on the MarketMoodz overbought/oversold meter, as of October 3, 2026. The Healthcare name (Medical Instruments & Supplies) last closed at $143.74. The rating moved from Neutral to Oversold on September 23, 2026.

• Public ratingOversold (as of October 3, 2026)
• Last close$143.74
• Last changeMoved from Neutral to Oversold on September 23, 2026
• SectorHealthcare
• IndustryMedical Instruments & Supplies

See all oversold Healthcare stocks →

AI analysis

Align Technology, Inc. (ALGN) combines a durable market-leading clear-aligner franchise with a growing digital-scanner and software ecosystem that drives recurring revenue and practitioner stickiness. The business benefits from sizable addressable markets, ongoing product innovation and strong cash generation, supporting multi-year growth opportunities. Near-term performance is exposed to elective dental demand, competitive pricing pressure and macro-driven risk-off sentiment, which could weigh on volumes and valuation. Monitoring scanner adoption rates, consumable growth, margin trends and any signs of accelerating competitive share shifts will be key to scenario updates.

Key factors

• Market-leading position in clear aligners with strong brand recognition and large installed base
• iTero intraoral scanners and digital ecosystem create recurring revenue, stickiness and cross-sell opportunities
• Solid historical revenue growth and gross margin profile driven by consumable sales and software/services
• Ongoing product and software innovation (AI treatment planning, digital workflows) supports long-term adoption
• International expansion and increasing penetration in emerging markets provide multi-year growth runway
• Improving cash flow generation enables reinvestment in R&D and potential buybacks or M&A

Risks

• Cyclical/elective nature of dental and orthodontic spending—macro risk and consumer/clinic postponements can compress volumes
• Intensifying competition as patents expire and established dental/device players and low-cost entrants expand aligner offerings
• Pricing pressure on consumables and services as competitors and DTC models seek market share
• Supply-chain disruptions or component shortages affecting iTero scanner deliveries and production
• Regulatory, reimbursement or professional-adoption hurdles in key markets that slow conversion to digital workflows
• Geopolitical and macro-driven risk-off market sentiment that can depress growth multiples and capital spending by practices

Latest MarketMoodz coverage

• Barclays Lifts Align to Overweight with $200 Target2026-03-17

This page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.